Volume 22; Issue 8

Main
Clinical Cancer Research
Volume 22; Issue 8

Clinical Cancer Research

Volume 22; Issue 8

1

Dendritic Cell-Based Immunotherapy: State of the Art and Beyond

Bol, K. F., Schreibelt, G., Gerritsen, W. R., de Vries, I. J. M., Figdor, C. G.

Journal:

Clinical Cancer Research

Year:

2016

Language:

english

File:

PDF, 805 KB

english, 2016

2

Making Better Chimeric Antigen Receptors for Adoptive T-cell Therapy

Maus, M. V., June, C. H.

Journal:

Clinical Cancer Research

Year:

2016

Language:

english

File:

PDF, 1.17 MB

english, 2016

3

The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition

Hegde, P. S., Karanikas, V., Evers, S.

Journal:

Clinical Cancer Research

Year:

2016

Language:

english

File:

PDF, 690 KB

english, 2016

4

Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines

Tu reci, O., Vormehr, M., Diken, M., Kreiter, S., Huber, C., Sahin, U.

Journal:

Clinical Cancer Research

Year:

2016

Language:

english

File:

PDF, 1.09 MB

english, 2016

5

Disruptive Immunology

Journal:

Clinical Cancer Research

Year:

2016

Language:

english

File:

PDF, 314 KB

english, 2016

6

Emerging Opportunities and Challenges in Cancer Immunotherapy

Whiteside, T. L., Demaria, S., Rodriguez-Ruiz, M. E., Zarour, H. M., Melero, I.

Journal:

Clinical Cancer Research

Year:

2016

Language:

english

File:

PDF, 811 KB

english, 2016

7

NOTCH1 and SOX10 are Essential for Proliferation and Radiation Resistance of Cancer Stem-Like Cells in Adenoid Cystic Carcinoma

Panaccione, A., Chang, M. T., Carbone, B. E., Guo, Y., Moskaluk, C. A., Virk, R. K., Chiriboga, L., Prasad, M. L., Judson, B., Mehra, S., Yarbrough, W. G., Ivanov, S. V.

Journal:

Clinical Cancer Research

Year:

2016

Language:

english

File:

PDF, 2.16 MB

english, 2016

8

Reversing T-cell Dysfunction and Exhaustion in Cancer

Journal:

Clinical Cancer Research

Year:

2016

Language:

english

File:

PDF, 859 KB

english, 2016

9

KDR Amplification Is Associated with VEGF-Induced Activation of the mTOR and Invasion Pathways but does not Predict Clinical Benefit to the VEGFR TKI Vandetanib

Nilsson, M. B., Giri, U., Gudikote, J., Tang, X., Lu, W., Tran, H., Fan, Y., Koo, A., Diao, L., Tong, P., Wang, J., Herbst, R., Johnson, B. E., Ryan, A., Webster, A., Rowe, P., Wistuba, I. I., Heymach

Journal:

Clinical Cancer Research

Year:

2016

Language:

english

File:

PDF, 1.23 MB

english, 2016